Sasko Kedev Selected Research

Sasko Kedev Research Topics

Disease

27	ST Elevation Myocardial Infarction 11/2022 - 08/2014
20	Acute Coronary Syndrome 11/2022 - 08/2013
16	Hemorrhage 01/2021 - 08/2013
14	Myocardial Infarction 11/2021 - 08/2014
11	Stroke (Strokes) 01/2021 - 09/2014
11	Thrombosis (Thrombus) 01/2021 - 02/2013
8	Heart Failure 11/2022 - 04/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2014
5	Infarction (Infarctions) 01/2020 - 03/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 10/2020 - 01/2018
3	Neoplasms (Cancer) 10/2018 - 02/2017
2	Ischemia 11/2021 - 09/2016
2	Hypercholesterolemia 04/2021 - 10/2020
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2019
2	Pathologic Constriction (Stenosis) 12/2019 - 01/2018
2	Ischemic Stroke 01/2019 - 12/2015
2	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2014
2	Cardiogenic Shock 08/2015 - 04/2015
1	Heart Diseases (Heart Disease) 11/2022
1	Carotid Stenosis (Carotid Artery Stenosis) 03/2022
1	Arteriovenous Fistula 01/2022
1	Death (Near-Death Experience) 11/2021
1	Transient Ischemic Attack 01/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2019
1	Pain (Aches) 01/2019
1	Unstable Angina 01/2019
1	Diabetes Mellitus 01/2018
1	Atherosclerosis 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Stable Angina 01/2018
1	Non-ST Elevated Myocardial Infarction 07/2017
1	Pulmonary Embolism 07/2017
1	Thrombocytopenia (Thrombopenia) 07/2017
1	Left Ventricular Dysfunction 03/2016
1	Chronic Renal Insufficiency 01/2016
1	Chest Pain (Chest Pains) 12/2015
1	Spasm (Spasms) 01/2014
1	Peripheral Arterial Disease 01/2013

Drug/Important Bio-Agent (IBA)

6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 02/2017
6	omega-Chloroacetophenone (Mace)IBA 11/2021 - 09/2014
5	Clopidogrel (Plavix)FDA Link 10/2019 - 07/2015
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 01/2018
3	MetalsIBA 01/2021 - 12/2017
3	TicagrelorIBA 10/2019 - 03/2016
3	Proton Pump InhibitorsIBA 10/2018 - 03/2016
3	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 07/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 02/2020 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2020 - 10/2018
2	AnticoagulantsIBA 01/2020 - 12/2015
1	Digoxin (Digitek)FDA LinkGeneric 11/2022
1	Triglycerides (Triacylglycerol)IBA 04/2021
1	Prasugrel Hydrochloride FDA Link 10/2019
1	PolymersIBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019
1	alirocumabIBA 01/2019
1	Biological ProductsIBA 10/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018
1	CreatinineIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2018
1	Troleandomycin (TAO)FDA Link 01/2018
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2018
1	PCSK9 InhibitorsIBA 01/2018
1	Eptifibatide (Integrilin)FDA Link 01/2018
1	AdipokinesIBA 01/2018
1	otamixabanIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Fibric Acids (Fibrates)IBA 01/2018
1	A-factor (Streptomyces)IBA 08/2017
1	gossypol acetic acidIBA 08/2017
1	TroponinIBA 08/2017
1	Pharmaceutical PreparationsIBA 07/2017
1	RivaroxabanIBA 07/2017
1	Protective AgentsIBA 02/2017
1	Enoxaparin (Lovenox)FDA LinkGeneric 07/2015
1	Sodium Glutamate (Accent)IBA 01/2013

Therapy/Procedure

34	Percutaneous Coronary Intervention 01/2021 - 02/2013
21	Therapeutics 11/2022 - 08/2013
9	Thrombectomy 01/2020 - 04/2015
8	Stents 03/2022 - 04/2015
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2018
3	Drug-Eluting Stents 01/2021 - 12/2017
3	Blood Transfusion (Blood Transfusions) 01/2018 - 10/2016
2	Punctures 01/2019 - 01/2014
1	Renal Dialysis (Hemodialysis) 01/2022
1	Transcatheter Aortic Valve Replacement 10/2019
1	Contraindications 01/2018
1	Thrombolytic Therapy 12/2015